Urology Reimbursement in 2027: Why CMS Projects a 2% Cut and How to Prepare

QUICK ANSWER

• How does the 2027 Medicare fee schedule affect urology billing? As of July 2026, the CY 2027 Medicare Physician Fee Schedule proposed rule (CMS-1848-P) estimates a net -2% impact on total Medicare allowed charges for urology. The reduction is driven by three overlapping proposals: a 50% payment cut for E/M visits billed same-day with global-period procedures using Modifier 25, changes to the practice expense calculation methodology, and the expiration of the 2.5% temporary conversion factor increase that applied only to 2026. Urology practices that bill Medicare for in-office procedures will feel this change most directly.
• Net -2% for urology: The American Urological Association’s initial analysis confirms a combined -2% impact from the conversion factor cut, Modifier 25 changes, PE methodology shifts, and the G2211 code transition.
• Same-day procedure billing takes the biggest hit: Urology practices routinely bill an E/M visit alongside cystoscopy, biopsy, vasectomy, or other in-office procedures. Under the proposal, the same-day E/M would be paid at 50%.
• Coding accuracy is the primary defense: The practices that will absorb the -2% are those with coding and documentation gaps. Practices with clean modifier usage, accurate E/M leveling, and correct PE capture can offset much of the reduction.

What CMS Proposed for Urology

On July 14, 2026, CMS published the CY 2027 Medicare Physician Fee Schedule proposed rule (CMS-1848-P). The American Urological Association published an initial summary confirming that CMS estimates a net -2% impact on total Medicare charges for urology if the proposals are finalized.

The -2% results from several overlapping changes. The overall conversion factor drops to $32.8409 for non-APM participants (a 1.68% reduction from 2026). CMS proposes reducing payment to 50% for any E/M visit billed same-day with a global-period procedure using Modifier 25. The practice expense methodology is being restructured in ways that shift reimbursement across specialties. And the G2211 visit complexity add-on code is being transitioned to a modifier that increases the associated E/M payment by 16% instead of a flat add-on.

For urology specifically, the Modifier 25 change and the global surgical period E/M overlap proposal carry the most financial weight. Urology is a procedure-heavy specialty where same-day evaluation and treatment is the norm, not the exception. A patient presenting for a cystoscopy evaluation, for example, almost always requires a separately identifiable E/M visit on the same date. Under the current rules, both services are paid in full. Under the proposed rule, the E/M drops to 50%.

Which Urology Procedures Are Most Affected?

The proposed Modifier 25 reduction affects any encounter where a urology practice bills an E/M visit on the same day as a procedure with a 0-, 10-, or 90-day global surgical period. In urology, that covers a wide range of common in-office services.

Cystoscopy (CPT 52000) is the highest-volume same-day procedure in most urology practices. It carries a 0-day global period, and the separately identifiable E/M visit is almost always warranted because the clinical evaluation for presenting symptoms is distinct from the diagnostic procedure. Under the proposed rule, the E/M portion of every cystoscopy encounter would be reduced to 50%. For a comprehensive look at how CPT 52000 billing works in practice, see our dedicated guide.

Other commonly affected procedures include prostate biopsies, vasectomies, circumcisions, urodynamic testing, stent removals, and in-office lithotripsy. Each of these frequently involves a same-day E/M evaluation that would fall under the 50% reduction if finalized.

Across the billing companies we vet for urology practices, the ones that flag same-day E/M volume as a key performance metric are already modeling this change. Practices that do not know their same-day E/M plus procedure volume cannot quantify the risk.

What Does a 2% Cut Actually Cost a Urology Practice?

A 2% reduction in total Medicare allowed charges sounds modest until you run the numbers on a real urology practice. Consider a two-urologist practice that bills $800,000 annually to Medicare. A 2% net reduction translates to $16,000 per year in lost revenue before accounting for any offsetting gains from the G2211 modifier transition.

But the -2% is an average across all urology services. Practices with a high procedural volume will see a disproportionately larger impact because the Modifier 25 change targets same-day E/M plus procedure encounters specifically. A practice that bills 20 same-day cystoscopies per week at an average E/M allowed amount of $100 loses roughly $50 per encounter, which compounds to approximately $52,000 per year from cystoscopy encounters alone.

The G2211 complexity modifier transition partially offsets the Modifier 25 cut, but only for visits that qualify. A routine cystoscopy evaluation in a patient without complex comorbidities may not meet the complexity criteria. Practices that do qualify for the 16% E/M bump on complex visits can recover roughly $16 per qualifying encounter, which reduces but does not eliminate the net loss.

One pattern we see among urology practices that reach out for billing help is that they have never modeled the financial impact of a payment policy change on their specific code mix. Knowing your top 20 codes and their same-day pairing frequency is the first step toward understanding whether the -2% applies evenly to your practice or concentrates on a few high-volume procedures.

How to Protect Urology Revenue in 2027

The proposed rule is open for public comment through September 14, 2026, and the final rule typically publishes in November. Urology practices should begin preparing now regardless of the final outcome:

1. Quantify your same-day E/M plus procedure volume. Pull a report of every claim from the last 12 months where Modifier 25 was appended to an E/M code alongside a procedure with a global period. This is your exposure baseline.
2. Model the 50% E/M reduction on your actual code mix. Multiply the average E/M allowed amount on those claims by 0.5 and calculate the annualized loss. Compare it against the aggregate -2% to see if your practice falls above or below the average.
3. Audit your E/M coding levels on procedure days. If your practice defaults to a level-3 E/M on cystoscopy days, you may be undercoding visits that support a higher level. A level-4 E/M at 50% still pays more than a level-3 at 50%. For a full breakdown of urology procedure and evaluation codes, see our urology CPT code guide.
4. Evaluate G2211 eligibility across your patient panel. The visit complexity add-on is transitioning to a modifier that increases E/M payment by 16%. Urology patients with multiple chronic conditions, ongoing surveillance protocols, or complex medication management may qualify.
5. Verify your global period billing accuracy. Ensure every procedure code on your fee schedule has the correct global period assigned. A coding error that assigns the wrong global period changes whether the same-day E/M is subject to the reduction.
6. Submit a public comment by September 14 if the Modifier 25 proposal affects your practice. The AUA is preparing a formal comment. Individual practice comments strengthen the advocacy effort, especially from smaller groups that can describe the real-world financial impact.

Common Urology Billing Errors That Compound the Cut

The -2% net impact assumes correct billing. In practice, many urology groups are already leaving revenue on the table through coding and documentation errors that the 2027 changes will amplify:

• Undercoding the E/M on procedure days. Urology practices frequently default to a level-3 E/M on days when a procedure is performed, even when the medical decision-making supports a level-4 or level-5. At 50% payment, the difference between a level-3 and a level-4 E/M is roughly $20 to $30 per encounter. Over hundreds of same-day encounters per year, that compounds into significant lost revenue.
• Failing to bill the separate E/M entirely. Some billing teams skip the same-day E/M when they are unsure whether Modifier 25 documentation is strong enough to survive an audit. This conservative approach costs the practice 50% of the E/M allowed amount (under the proposed rule) instead of zero.
• Incorrect global period assignment. If a procedure is assigned the wrong global period in the practice management system, the payer may apply the same-day reduction incorrectly or deny the E/M claim outright. Keeping global period tables current for every urological procedure code is a maintenance task that generalist billing companies frequently overlook.

For practices concerned about whether their billing processes meet current compliance standards, our guide on urology billing compliance covers the documentation and coding requirements specific to urology.

2026 vs. 2027 Urology Billing Comparison

The table below illustrates the proposed changes using common urology billing scenarios.

The numbers above are estimates based on the proposed rule tables and typical urology allowed amounts. Actual impact varies by locality, payer mix, and the specific code distribution of each practice. CMS will publish the final values in the November 2026 final rule.

CPT codes and descriptors are maintained by the American Medical Association and are provided here for reference. Bundling, modifier, and global-period rules vary by payer and by Medicare contractor, so verify against current CPT guidelines, the current NCCI edit file, and payer policies before billing.

Frequently Asked Questions

Next Steps

• Pull your Modifier 25 same-day E/M volume from the last 12 months and calculate your annualized exposure under the proposed 50% reduction.
• Review our urology CPT code guide to confirm your coding aligns with the 2027 proposed rules for your most-billed procedures.
• Request a free quote to compare urology billing companies that specialize in procedural coding, modifier compliance, and revenue optimization.